Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harborview Master Fund, L.P. was a New York-based investment fund specializing in the healthcare and life sciences sectors. Managed by Harborview Advisors, LLC and led by principals David Stefansky and Richard Rosenblum, the fund focused on providing growth capital to emerging biotechnology, pharmaceutical, and medical device companies. The firm was particularly known for its active involvement in Private Investment in Public Equity (PIPE) transactions and often placed its principals on the boards of its portfolio companies to drive strategic value. Notable investments included Alliqua Biomedical, Generex Biotechnology, Bacterin International, and Aastrom Biosciences. The fund is currently considered inactive as its principals have transitioned to other investment vehicles, such as Bezalel Capital Partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harborview Master Fund.